Applied Pharmaceutical Nanotechnology 2019

October 25, 2019

Pfizer

1 Portland Street

Cambridge, MA 02139 

 

 

Plenary Speakers for APN 2019

 

Greg Troiano, MSE, Vice President of Technology and Chief Engineer, Seer, Inc.

Biomolecular Biosensors for Health Monitoring and Disease Detection - An Update

     
 

Ulrich van Andrian, M.D., Ph.D. Mallinckrodt Professor of Immunopathology, Harvard Medical School

Title TBA

 

Confirmed Speakers for APN 2019

   

Gilles Besin, PhD, Sr. Director, Immunology, Moderna Therapeutics

Title TBA

     
   

Richard Huang, PhD, Senior Director, L.E.A.F. Pharmaceuticals

Title TBA

     
   

Clarice Hutchens, PhD, Senior Director, Pfizer

Title TBA

     
   

Hakho Lee, Ph.D., Associate Professor, Harvard Medical School 

Title TBA

     
   

Christopher Locher, Ph.D., CEO and Founder, Versatope Therapeutics 

Title TBA

     
   

Young-Ho Song, Pfizer 

Title TBA

     
   

Gokul Swaminathan, PhD, Associate Principal Scientist, Merck Exploratory Science Center, Merck Research Laboratories

Novel Immuno-Modulatory Lipid Nanoparticle Formulations for Vaccines and Immuno-Oncology Applications

     
   

Shraddha Thakkar, PhD, Principal Investigator, U.S. FDA

Title TBA

 

Proposed Sessions for 2019: 

Session I: Particle Technology : Early and Late Stage Technology

Session II: Impact of Biology and Immunology in Nanotechnology

Session III: Regulatory Aspects of Nanotechnology

 

 

 

Please Join our Linkedin Group

Sessions

Session I: TBA

Session II: TBA

Session III: TBA

Registration

Click here to register for the APN 2019 conference online.

APN 2019 will take place October 25, 2019 at:

Pfizer, Cambridge, MA

 

The Boston Society

The Boston Society (R) is an internationally-recognized NON-PROFIT organization dedicated to bringing the best scientific ideas to industrial practice through focused, timely workshops and conferences. 501(c)3

Updates

Sign Up Today!

Privacy Policy